[Pathophysiology of CADASIL disease]

Alberto Del Río Espínola1, Esther Solé, Joan Montaner

  • 1Laboratorio de Investigación Neurovascular, Departamento de Medicina, Universidad Autónoma de Barcelona, Institut de Recerca, Hospital Vall d'Hebrón Barcelona, España.

Medicina Clinica
|December 29, 2009
PubMed

Insights

Investigating Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), this review evaluates seven pathogenic models. Understanding CADASIL

Area of Science:

  • Neurology
  • Genetics
  • Vascular Biology

Background:

  • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a well-characterized genetic disorder.
  • The precise pathogenic mechanisms driving CADASIL remain incompletely understood.
  • The Notch pathway's conservation facilitates the development of relevant animal and cellular models.

Purpose of the Study:

  • To critically assess the validity of seven proposed pathogenic models for CADASIL.
  • To explore the connection between vascular smooth muscle cell (VSMC) degeneration, ischemic lesions, and clinical manifestations.
  • To discuss theories explaining the neurological predominance of this systemic arteriopathy.

Main Methods:

  • Review and analysis of existing literature on CADASIL.
  • Evaluation of seven distinct pathogenic models: autoimmune origin, mitochondrial dysfunction, Notch3 loss-of-function, GOM toxicity, and UPR activation.
  • Discussion of VSMC degeneration, ischemic events, and symptom correlation.

Main Results:

  • The review critically examines the strengths and limitations of each of the seven CADASIL pathogenic models.
  • The relationship between VSMC pathology, ischemic lesions, and the resulting clinical symptoms is analyzed.
  • The review highlights the systemic nature of CADASIL, despite its predominantly neurological presentation.

Conclusions:

  • No single model fully explains CADASIL pathogenesis, necessitating further research.
  • Understanding the interplay between VSMC dysfunction and neurological impact is crucial.
  • CADASIL is a systemic vascular disease with specific neurological manifestations.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...